BRIEF—GenScript Biotech expands synthetic biology product portfolio – The Pharma Letter
|
BRIEF—GenScript Biotech expands synthetic biology product portfolio
The Pharma Letter "The acquisition of CustomArray further strengthens our synthetic biology product portfolio with a unique technology that we believe will enhance our customers' ability to accelerate innovation in drug discovery and development, genome editing, protein … |
